Dr Thomas Michael Fitzpatrick, MD | |
Wramc, Building 2, Room 2j38, 6900 Georgia Avenue, Nw, Washington, DC 20307-0001 | |
(202) 356-0778 | |
Not Available |
Full Name | Dr Thomas Michael Fitzpatrick |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | Wramc, Building 2, Room 2j38, Washington, District Of Columbia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033267109 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | D0042742 (Maryland) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | MD17605 (District Of Columbia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Thomas Michael Fitzpatrick, MD Wramc, Building 2, Room 2j38, 6900 Georgia Avenue, Nw, Washington, DC 20307-0001 Ph: (202) 356-0778 | Dr Thomas Michael Fitzpatrick, MD Wramc, Building 2, Room 2j38, 6900 Georgia Avenue, Nw, Washington, DC 20307-0001 Ph: (202) 356-0778 |
News Archive
While automated external defibrillators improve survival for out-of-hospital cardiac arrest, an analysis of data indicates their use for cardiac arrest in a hospital does not result in an improved rate of survival, according to a study in the November 17 issue of JAMA. The study is being released early online because it will be presented at the American Heart Association's annual meeting.
A lengthy study performed at Methodist Extended Care Hospital resulted in the elimination of potentially deadly infections. The study findings were reported in a scientific poster presentation at the recent annual meeting of the Association for Vascular Access (AVA), a leading national organization focusing on patient safety and best nursing practices.
An international team led by researchers at the Austrian Institute of Molecular Biotechnology in Vienna and the University of Maryland School of Medicine in Baltimore discovered that genetically determined breast cancer can be largely prevented by blocking a bone gene. An already approved drug could be quickly available and would then be the first breast cancer prevention drug.
For many of the 200,000 patients diagnosed with Parkinson's disease in the United States every year, the diagnosis often occurs only after the appearance of severe symptoms such as tremors or speech difficulties.
› Verified 6 days ago
Dr. Adefolaju Oketokun, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |